BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11536259)

  • 1. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
    Prenat Diagn; 2001 Aug; 21(8):627-9. PubMed ID: 11536259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation.
    Chen M; Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
    Prenat Diagn; 2002 Jul; 22(7):576-8. PubMed ID: 12124691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly nuchal translucency measurements in normal fetuses.
    Pajkrt E; de Graaf IM; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Obstet Gynecol; 1998 Feb; 91(2):208-11. PubMed ID: 9469277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
    Spencer K; Ong CY; Liao AW; Papademetriou D; Nicolaides KH
    Prenat Diagn; 2000 Aug; 20(8):673-5. PubMed ID: 10951481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuchal cord and nuchal translucency measurements between 10th and 14th weeks of gestation].
    Czekierdowski A; Sodowski K; Cnota W; Kraczkowski J
    Ginekol Pol; 2001 Dec; 72(12A):1596-601. PubMed ID: 11883322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
    Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
    Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal translucency measurement in normal fetuses.
    Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
    Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population.
    Braithwaite JM; Morris RW; Economides DL
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1201-4. PubMed ID: 8968236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
    Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anatomy of nuchal translucency at 10-14 weeks gestation in fetuses with trisomy 21: An incredible medical mystery.
    Nafziger E; Vilensky JA
    Clin Anat; 2014 Apr; 27(3):353-9. PubMed ID: 24488865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
    Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
    Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.